Clinical trials · Missouri
Atherosclerosis clinical trials in Missouri
We’re tracking 6 recruiting atherosclerosis studies with a site in Missouri — including Phase 1, Phase 2 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in Missouri
- NCT07303777RecruitingPhase 2
Study of ABP-745 for people with atherosclerosis
This trial tests a new medication called ABP-745 to see if it helps people with atherosclerosis (hardening of the arteries). It is for people who are already taking a cholesterol-lowering medicine and who have had a special heart artery X-ray (coronary angiography).
St Louis, MissouriAges 18–75 - NCT07521007RecruitingPhase 2
YN001 treatment for coronary artery disease
This study tests whether a new drug called YN001 can help people with coronary atherosclerosis (narrowing of heart blood vessels). The trial aims to see if it can improve outcomes in people who have early-stage blockages in their heart arteries.
St Louis, MissouriAges 18–80 - NCT04537403RecruitingPhase 1
PET scan study of artery inflammation marker in plaque
This Phase 1 study tests whether a special PET scan can detect a specific inflammation signal (CCR2) in atherosclerosis—fatty plaque buildup in blood vessels. It may help future doctors better see which plaques are more inflamed and potentially more dangerous.
St Louis, MissouriAges 18–89 - NCT05235464Recruiting
Testing a high-protein diet for heart plaque risk
This study checks whether eating more protein affects atherosclerosis, which is plaque buildup in artery walls. It may help researchers understand if a high-protein approach changes health markers linked to heart disease.
Columbia, MissouriAges 45–75 - NCT05838547Recruiting
PET-MR scan study for narrowing in the carotid artery
This study tests how well a special PET-MR scan can help evaluate carotid artery plaque in people who have significant narrowing but no symptoms. It may help researchers better understand disease activity to guide treatment decisions like medication alone or medication plus surgery.
St Louis, MissouriAges 18 years+ - NCT02915198RecruitingPhase 4
Metformin for prediabetes to reduce heart and blood-vessel events
This trial tests whether taking metformin in people with prediabetes can lower the chance of future heart attack, stroke, or other blood-vessel problems. You may be a good fit if you have prediabetes plus existing cardiovascular disease or significant blood-vessel disease.
Kansas City, MissouriAges 18 years+
Where these studies are running in Missouri
Institutions with a site for the recruiting atherosclerosis studies listed above.
- Washington University in St. Louis · 3 studies
- Barnes-Jewish Center for Clinical Imaging Research
- Ellis Fischel Cancer Center / MU Health - University Hospital
- Kansas City VA Medical Center
What taking part in a atherosclerosis study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Atherosclerosis trials in other states
Common questions
- Are there atherosclerosis clinical trials in Missouri?
- Yes. We're currently tracking 6 recruiting atherosclerosis studies with a site in Missouri, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a atherosclerosis study in Missouri?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Missouri to take part?
- Not necessarily. These studies have a site in Missouri, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a atherosclerosis trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New atherosclerosis studies open in Missouri regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.